Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations

Andrew C. Picel, Sonya J. Koo, Anne C. Roberts

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose: The purpose of the study was to evaluate the technique and outcomes of transcatheter arterial embolization (TAE) with n-butyl cyanoacrylate (NBCA) for the treatment of acquired uterine arteriovenous malformations (AVMs). Materials and methods: A retrospective review identified five women treated for suspected acquired uterine AVMs with TAE at our institution. Four women (80 %) presented with heavy or intermittent vaginal bleeding after obstetric manipulation. One woman (20 %) was treated for an incidental AVM discovered on ultrasound after an uncomplicated cesarean section. Three women underwent one embolization procedure and two women required two procedures. Embolization material included NBCA in six procedures (80 %) and gelatin sponge in one procedure (20 %). Results: Embolization resulted in angiographic stasis of flow in all seven procedures. Four women (80 %) presented with vaginal bleeding which was improved after treatment. One woman returned 24 days after unilateral embolization with recurrent bleeding, which resolved after retreatment. One woman underwent two treatments for an asymptomatic lesion identified on ultrasound. There were no major complications. Three women (60 %) experienced mild postembolization pelvic pain that was controlled with non-steroidal anti-inflammatory drugs. Three women (60 %) had pregnancies and deliveries after embolization. Conclusions: TAE is a safe alternative to surgical therapy for acquired uterine AVMs with the potential to maintain fertility. Experience from this case series suggests that NBCA provides predictable and effective occlusion.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalCardioVascular and Interventional Radiology
DOIs
StateAccepted/In press - Mar 28 2016

Fingerprint

Cyanoacrylates
Vascular Malformations
Arteriovenous Malformations
Therapeutics
Uterine Hemorrhage
Retreatment
Pelvic Pain
Porifera
Gelatin
Cesarean Section
Obstetrics
Fertility
Anti-Inflammatory Agents
Hemorrhage

Keywords

  • n-Butyl cyanoacrylate
  • Transcatheter arterial embolization
  • Uterine arteriovenous fistula
  • Uterine arteriovenous malformation
  • Uterine vascular malformation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{2d6b57c868514fa2b30c7d8aa81bc266,
title = "Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations",
abstract = "Purpose: The purpose of the study was to evaluate the technique and outcomes of transcatheter arterial embolization (TAE) with n-butyl cyanoacrylate (NBCA) for the treatment of acquired uterine arteriovenous malformations (AVMs). Materials and methods: A retrospective review identified five women treated for suspected acquired uterine AVMs with TAE at our institution. Four women (80 {\%}) presented with heavy or intermittent vaginal bleeding after obstetric manipulation. One woman (20 {\%}) was treated for an incidental AVM discovered on ultrasound after an uncomplicated cesarean section. Three women underwent one embolization procedure and two women required two procedures. Embolization material included NBCA in six procedures (80 {\%}) and gelatin sponge in one procedure (20 {\%}). Results: Embolization resulted in angiographic stasis of flow in all seven procedures. Four women (80 {\%}) presented with vaginal bleeding which was improved after treatment. One woman returned 24 days after unilateral embolization with recurrent bleeding, which resolved after retreatment. One woman underwent two treatments for an asymptomatic lesion identified on ultrasound. There were no major complications. Three women (60 {\%}) experienced mild postembolization pelvic pain that was controlled with non-steroidal anti-inflammatory drugs. Three women (60 {\%}) had pregnancies and deliveries after embolization. Conclusions: TAE is a safe alternative to surgical therapy for acquired uterine AVMs with the potential to maintain fertility. Experience from this case series suggests that NBCA provides predictable and effective occlusion.",
keywords = "n-Butyl cyanoacrylate, Transcatheter arterial embolization, Uterine arteriovenous fistula, Uterine arteriovenous malformation, Uterine vascular malformation",
author = "Picel, {Andrew C.} and Koo, {Sonya J.} and Roberts, {Anne C.}",
year = "2016",
month = "3",
day = "28",
doi = "10.1007/s00270-016-1328-z",
language = "English (US)",
pages = "1--7",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Transcatheter Arterial Embolization with n-Butyl Cyanoacrylate for the Treatment of Acquired Uterine Vascular Malformations

AU - Picel, Andrew C.

AU - Koo, Sonya J.

AU - Roberts, Anne C.

PY - 2016/3/28

Y1 - 2016/3/28

N2 - Purpose: The purpose of the study was to evaluate the technique and outcomes of transcatheter arterial embolization (TAE) with n-butyl cyanoacrylate (NBCA) for the treatment of acquired uterine arteriovenous malformations (AVMs). Materials and methods: A retrospective review identified five women treated for suspected acquired uterine AVMs with TAE at our institution. Four women (80 %) presented with heavy or intermittent vaginal bleeding after obstetric manipulation. One woman (20 %) was treated for an incidental AVM discovered on ultrasound after an uncomplicated cesarean section. Three women underwent one embolization procedure and two women required two procedures. Embolization material included NBCA in six procedures (80 %) and gelatin sponge in one procedure (20 %). Results: Embolization resulted in angiographic stasis of flow in all seven procedures. Four women (80 %) presented with vaginal bleeding which was improved after treatment. One woman returned 24 days after unilateral embolization with recurrent bleeding, which resolved after retreatment. One woman underwent two treatments for an asymptomatic lesion identified on ultrasound. There were no major complications. Three women (60 %) experienced mild postembolization pelvic pain that was controlled with non-steroidal anti-inflammatory drugs. Three women (60 %) had pregnancies and deliveries after embolization. Conclusions: TAE is a safe alternative to surgical therapy for acquired uterine AVMs with the potential to maintain fertility. Experience from this case series suggests that NBCA provides predictable and effective occlusion.

AB - Purpose: The purpose of the study was to evaluate the technique and outcomes of transcatheter arterial embolization (TAE) with n-butyl cyanoacrylate (NBCA) for the treatment of acquired uterine arteriovenous malformations (AVMs). Materials and methods: A retrospective review identified five women treated for suspected acquired uterine AVMs with TAE at our institution. Four women (80 %) presented with heavy or intermittent vaginal bleeding after obstetric manipulation. One woman (20 %) was treated for an incidental AVM discovered on ultrasound after an uncomplicated cesarean section. Three women underwent one embolization procedure and two women required two procedures. Embolization material included NBCA in six procedures (80 %) and gelatin sponge in one procedure (20 %). Results: Embolization resulted in angiographic stasis of flow in all seven procedures. Four women (80 %) presented with vaginal bleeding which was improved after treatment. One woman returned 24 days after unilateral embolization with recurrent bleeding, which resolved after retreatment. One woman underwent two treatments for an asymptomatic lesion identified on ultrasound. There were no major complications. Three women (60 %) experienced mild postembolization pelvic pain that was controlled with non-steroidal anti-inflammatory drugs. Three women (60 %) had pregnancies and deliveries after embolization. Conclusions: TAE is a safe alternative to surgical therapy for acquired uterine AVMs with the potential to maintain fertility. Experience from this case series suggests that NBCA provides predictable and effective occlusion.

KW - n-Butyl cyanoacrylate

KW - Transcatheter arterial embolization

KW - Uterine arteriovenous fistula

KW - Uterine arteriovenous malformation

KW - Uterine vascular malformation

UR - http://www.scopus.com/inward/record.url?scp=84961644494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961644494&partnerID=8YFLogxK

U2 - 10.1007/s00270-016-1328-z

DO - 10.1007/s00270-016-1328-z

M3 - Article

C2 - 27021069

AN - SCOPUS:84961644494

SP - 1

EP - 7

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

ER -